I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Condition(s):COVID-19Last Updated:March 19, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:March 19, 2024Recruiting
Condition(s):Gastric CancerLast Updated:November 7, 2012Completed
Condition(s):Endocrine/Neuroendocrine; Non-Small Cell Lung Cancer; Breast Cancer; Gastrointestinal/Genitourinary Cancers; Ovarian CancerLast Updated:March 12, 2024Withdrawn
Condition(s):Chronic Hepatitis BLast Updated:December 21, 2022Recruiting
Condition(s):Human Papillomavirus; HPV-16; High Grade Squamous Intraepithelial LesionLast Updated:February 16, 2021Terminated
Condition(s):Pompe DiseaseLast Updated:August 28, 2023Active, not recruiting
Condition(s):AML, Childhood; Aml; Acute Myeloid Leukemia, Pediatric; Acute Myeloid LeukemiaLast Updated:December 6, 2023Not yet recruiting
Condition(s):Sickle Cell Anemia; Beta ThalassemiaLast Updated:March 15, 2024Recruiting
Condition(s):Chronic Hepatitis bLast Updated:November 26, 2019Unknown status
Condition(s):HBsAg-positive Renal Allograft RecipientsLast Updated:September 9, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.